Page 3 - Clark Endowed Professor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Colorectal Cancer Gene Implicated in Broad Range of Solid Tumors

A gene associated with colorectal cancer appears to also play a role in the development of other solid tumors, according to a study of over 350,000 patient biop

United statesUnited kingdomChanning pallerJohns hopkinsAlexandra maertensEmmanuel antonarakisJohns hopkins kimmel cancer centerResearch programsDepartment of defenseJohns hopkins bloomberg school of public healthUniversity of minnesota medical schoolCardiff university school of medicineJohns hopkins universityNational institutes of healthBloomberg school of public healthMasonic cancer center

Community/Academic Research Collaboration Paves the Way for Improved Cancer Care

Gautam Jha, MD, and Emmanuel Antonorakis, MD, discuss the ins and outs of clinical trial partnerships between community and academic cancer centers.

University of minnesotaUnited statesGautam jhaEmmanuel antonorakisM health masonic fairview cancer centerTranslational researchTreatment centerM health fairview ridges hospitalM health fairview clinicsSurgery centerUniversity of minnesota masonic cancer centerAdvanced treatment centerClark endowed professorMinnesota masonic cancer center

New Immunotherapy Agent Tested Safe And Promising

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimme

United statesJohns hopkins universityMohamad el allafChristianp pavlovichJohns hopkinsEmmanuels antonarakisCarolyn chapmanEugene shenderovTamaral lotanEli lillySamuelr denmeadeKennethj pientaZhao wangHogkai jiProstate cancer foundation young investigator awardNanostring technologies inc

Immunotherapy could be effective for treatment of prostate cancer: Study

Washington, April 9: According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.

United statesEmmanuels antonarakisEugene shenderovChristophe galtierJohns hopkins kimmel cancer centerJohns hopkins university school of medicineBloomberg kimmel institute for cancer immunotherapyBloomberg kimmel instituteJohns hopkins university schoolClark endowed professorMinnesota masonic cancerJohns hopkins kimmel cancerImmunotherapy could be effective for treatment of prostate cancer study

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

United statesJohns hopkins universityCharlesg drakeMohamad el allafJohns hopkinsEli lillySamuelr denmeadeHogkai jiZhao wangKennethj pientaEugene shenderovCarolyn chapmanChristianp pavlovichTamaral lotanEmmanuels antonarakisOncology at janssen research